A Phase 1B/2A Trial of Combination of ASTX727 With ASTX029 in Acute Myeloid Leukemia

NCT06113289 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped PI Request

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: ASTX727
DRUG: ASTX029-01

Sponsor

M.D. Anderson Cancer Center